COMBIVIR
- Product NDC
- 50090-0610
- 11-digit product format
- 500900610
- Labeler code
- 50090
- Product ID
- 50090-0610_6bcd98d7-f0f8-4b4a-90c2-a9f5fbf030f8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- lamivudine and zidovudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- NDA020857
- Marketing category
- NDA
- Marketing start
- 2010-10-19
- Marketing end
- 0000-00-00
- Substance
- LAMIVUDINE; ZIDOVUDINE
- Active strength
- 150 mg/1; mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record